Hoshi Taku, Kitagawa Kazuo, Yamagami Hiroshi, Furukado Shigetaka, Hougaku Hidetaka, Hori Masatsugu
Osaka University, Graduate School of Medicine, Division of Stroke Research, Department of Cardiovascular Medicine, 2-2 Yamada-oka, Suita, Osaka 565-0871, Japan.
Atherosclerosis. 2008 Mar;197(1):326-32. doi: 10.1016/j.atherosclerosis.2007.05.013. Epub 2007 Jun 29.
The levels of systemic inflammatory markers have been shown to predict future cardiovascular events, but whether they are associated with intracranial large-artery atherosclerosis is uncertain. We investigated the relation between the level of inflammatory markers interleukin-6 (IL-6) and high-sensitivity C-reactive protein (hsCRP) and subclinical intracranial large-artery atherosclerosis in patients with risk factors for atherosclerosis.
Magnetic resonance angiography (MRA) was performed in 226 Japanese patients age range, 45-87 years without a history of cerebrovascular disease. Serum IL-6 and hsCRP and conventional risk factors for atherosclerosis were assessed.
Forty-six patients (20.4%) were found by MRA to have one or more intracranial steno-occlusive lesions. Mean IL-6 levels were higher in patients with intracranial large-artery atherosclerosis than in those without. In addition, patients in the highest IL-6 tertile had higher unadjusted odds ratio (OR) for intracranial large-artery atherosclerosis than that of those in the lowest tertile (OR 3.25, 95% CI; 1.42-7.39). These associations were only slightly attenuated upon adjustment for conventional atherosclerotic risk factors and carotid intima-media thickness.
Increased levels of IL-6 appear to be associated with intracranial large-artery disease, suggesting a role for the inflammatory process in atherosclerosis of intracranial large arteries.
全身炎症标志物水平已被证明可预测未来心血管事件,但它们是否与颅内大动脉粥样硬化相关尚不确定。我们调查了炎症标志物白细胞介素-6(IL-6)和高敏C反应蛋白(hsCRP)水平与动脉粥样硬化危险因素患者亚临床颅内大动脉粥样硬化之间的关系。
对226名年龄在45 - 87岁、无脑血管疾病病史的日本患者进行磁共振血管造影(MRA)。评估血清IL-6、hsCRP以及动脉粥样硬化的传统危险因素。
MRA发现46名患者(20.4%)有一个或多个颅内狭窄闭塞性病变。颅内大动脉粥样硬化患者的平均IL-6水平高于无此病的患者。此外,IL-6水平处于最高三分位数的患者发生颅内大动脉粥样硬化的未调整优势比(OR)高于最低三分位数的患者(OR 3.25,95% CI:1.42 - 7.39)。在对传统动脉粥样硬化危险因素和颈动脉内膜中层厚度进行调整后,这些关联仅略有减弱。
IL-6水平升高似乎与颅内大动脉疾病相关,提示炎症过程在颅内大动脉粥样硬化中起作用。